tiprankstipranks
STRATEC Biomedical AG (DE:SBS)
XETRA:SBS
Germany Market

STRATEC Biomedical (SBS) Income Statement

Compare
3 Followers

STRATEC Biomedical Income Statement

Last quarter (Q3 2024), STRATEC Biomedical's total revenue was €57.23M, a decrease of -8.69% from the same quarter last year. In Q3, STRATEC Biomedical's net income was €549.00K. See STRATEC Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 261.91M€ 274.63M€ 287.33M€ 250.10M€ 221.64M
Gross Profit
€ 64.84M€ 79.49M€ 87.71M€ 68.99M€ 52.10M
Operating Expenses
€ 41.96M€ 36.74M€ 37.26M€ 34.93M€ 31.85M
Depreciation and Amortization
€ 17.69M€ 16.93M€ 17.21M€ 18.49M€ 18.70M
EBITDA
€ 39.82M€ 57.53M€ 65.45M€ 52.59M€ 36.09M
Operating Income
€ 22.89M€ 41.78M€ 50.78M€ 32.48M€ 19.11M
Other Income/Expenses
€ -4.66M€ -922.00K€ -667.00K€ 576.00K€ -1.72M
Pretax Income
€ 18.23M€ 39.09M€ 46.83M€ 33.02M€ 18.32M
Net Income
€ 13.07M€ 29.22M€ 39.96M€ 25.18M€ 14.44M
Per Share Metrics
€ ―€ ―€ ―€ ―€ ―
Basic EPS
€ 1.07€ 2.41€ 3.30€ 2.42€ 1.34
Diluted EPS
€ 1.07€ 2.40€ 3.28€ 2.40€ 1.33
Weighted Average Shares Outstanding
12.16M 12.13M 12.11M 12.06M 11.99M
Weighted Average Shares Outstanding (Diluted)
12.16M 12.17M 12.18M 12.15M 12.06M
Currency in EUR

STRATEC Biomedical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis